Alex Rolland, BSc (Honours with distinction) Molecular/Cell Biology
Co-founder, CEO, and Chief Research Director
Precision Oncology expert Alex Rolland is Chief Research Director and co-founder of Cancer Treatment Options and Management. Alex is passionate about ensuring that anyone who receives a cancer diagnosis has access to the most effective, and least invasive, form of treatment possible.
Alex holds a BSc in Molecular/Cell Biology from the University of Victoria, and studied Medical Genetics at the renowned Terry Fox Laboratory in Vancouver (BC Cancer Agency). He excelled in courses on cell biology, molecular biology, biochemistry, microbiology, immunology, organic chemistry, medical genetics, bioinformatics, and ecology, and specialized in epigenetics-based regulation of oncogenic signalling pathways.
Alex has led multiple research studies at the University of Victoria and the University of British Columbia, and taught cell biology and genetics labs at the University of Victoria, BC. He’s also used his expertise to consult oncologists at the Mayo Clinic and other leading cancer treatment centers.
With over a decade of experience researching, consulting, and advocating for cancer patients, Alex also works directly with the medical system to explore the newest optimal treatments for his clients. He’s an expert in discovering how to optimize your cancer treatment, and making this a reality for you.
Having deeply studied the molecular, biochemical, immunological, and clinical treatment of cancer, Alex knows that understanding cancer requires a multidisciplinary approach.
This level of knowledge – understanding cancer, inside and out – and his professional experience in cancer research, education, and advocacy (for clients undergoing standard treatment) has allowed him to see where both the strengths and limitations really exist in current standard cancer treatment practices.
Alex’s insights have led him to see the reality of standard treatment: the problem with current standard cancer treatment is not a lack of effective treatment options. In fact, there are many evidence-based treatments that are known to have a direct, positive impact on cancer treatment.
The real problems with current standard cancer treatment are time and budgetary constraints within the health care system.
This lack of time and money causes many of the doctors, oncologists, and health care teams working on the front lines within the public health system (in cancer clinics, hospitals, etc.) to miss out on the latest advancements in new, effective diagnostic measures and treatments.
Significantly, when the most recent developments in cancer treatment research and technology fail to reach doctors and health care teams on the front lines, they fail to reach patients like you.
Advancements in cancer treatment have led to precision oncology, which uses cutting-edge genetic testing and targeted therapies, that can either slow or stop tumour growth and produce higher survival rates with fewer and less severe side effects than current standard practices.
But this precision oncology approach has not yet been integrated into the public health care system. The real-world consequence is that potentially life-saving treatments are not reaching cancer patients who need effective, individualized treatment options now.
At the time Alex discovered this disillusioning reality of standard cancer treatment practices, he was pursuing graduate studies at the acclaimed Terry Fox Laboratory at the BC Cancer Agency. Time and again he saw how the limitations of the public medical system failed cancer patients across the board.
He knew he could provide a solution to this serious problem – so he put his graduate studies on hold and established Cancer Treatment Options and Management in order to serve people with cancer in the most needed way. Since then, Alex has dedicated his professional career to advocating for people who need cancer treatment – to ensure they have access to the most advanced tests and treatments that will benefit them the most. He’s in your corner.
Alex is passionately committed to making sure that anyone who receives a cancer diagnosis has the chance to access the most effective and least invasive form of treatment available in the world.
He’s helped many clients go from being told there was nothing more that could be done for them (and to start palliative care) to recovering from cancer. There is hope. And it’s fast – within just 10 days of contracting us you’ll receive essential information to help you and your treatment team make more informed choices. Read some of our success stories, to hear how previous clients have been helped by CTOAM’s services.
If you want to learn more about how Chief Research Director with member of our Medical Services Team can help you get the most beneficial treatment for your form of cancer, contact us now – register for a Precision Second Opinion today, or reach out to our CTOAM care team to ask any questions.
Get the latest advancements in cancer care delivered straight to your inbox each month!